Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to market its generic Sacubitril and Valsartan tablets combination used to treat chronic heart failure in adults.The approval by the US Food and Drug Administration (USFDA) is to market Sacubitril an...
Liking and disliking news Highlights will help Daily News Highlights to understand visitor interests and top trends as per the user behavior hence this feature requires visitor to Sign In, if you are not registered yet, please Sing Up to personalize your reading.